baber/WOPTO huggingface dataset:
Patent EP-1963521-A2 (EP)
Inventor: BRISTOW CYNTHIA
IPC: C12Q1/37
Filed: 2006-12-06
Abstract: A previously unrecognized fundamental property of α1PI is to regulate the phenotypic composition of circulating and tissue-associated cells derived from hematopoietic stem cells. The present invention comprises screening for various unmodified and modified α1PI's which are useful in the treatment of abnormalities in the number of cells of myeloid or lymphoid lineage that are associated with HIV-I infection, microbial infection, leukemia, solid tumor cancers, atherosclerosis, autoimmunity, stem cell transplantation, organ transplantation, and other diseases affected by cells of the immune system. The interaction of α1PI with its receptors, HLEcs and LRP, influences the level of cells of different lineages. Genetic and proteolytic modification of α1PI is used to target these receptors to increase or decrease specific cell populations, as needed, in the various disease states.
Patent EP-1924849-A2 (EP)
Inventor: REYNIER YVAN
IPC: G01N27/416
Filed: 2006-08-03
Abstract: The present invention provides systems (100) and methods for accurately characterizing thermodynamic and materials properties of electrodes and electrochemical energy storage (1 15) and conversion systems Systems and methods of the present invention are capable of simultaneously collecting a suite of measurements (110) characterizing a plurality of interconnected electrochemical and thermodynamic parameters relating to the electrode reaction state of advancement, voltage (130) and temperature Enhanced sensitivity provided by the present methods and systems combined with measurement conditions that reflect thermodynamically stabilized electrode conditions allow very accurate measurement of thermodynamic parameters, including state functions such as the Gibbs free energy, enthalpy and entropy of electrode/electrochemical cell reactions, that enable prediction of important performance attributes of electrode materials and electrochemical systems, such as the energy, power density, current rate and the cycle life of an electrochemical cell (115)
Patent EP-1773105-A2 (EP)
Inventor: TOYODA YUKIHIKO
IPC: H01L21/48
Filed: 2002-03-13
Abstract: The invention provides a multilayered printed circuit board comprising a substrate and, as serially built up thereon, a conductor circuit and an interlaminar resin insulating layer in an alternate fashion and in repetition, and a solder resist layer formed further thereon as an outermost layer, with a connection of said conductor circuits through said interlaminar resin insulating layer being performed by a via-hole, wherein via-holes in different level layers among said via-holes are piled on one another, and among said piled via-holes, at least one via-hole is piled on other via-holes with its center deviated from other via-holes, and other via-holes are piled on one another with those centers approximately overlapped with one another.
Patent EP-1840188-A2 (EP)
Inventor: KILICKIRAN PINAR
IPC: C09K19/54
Filed: 2007-02-28
Abstract: The present invention relates to a composition comprising at least one type of liquid crystal, to a liquid crystal cell and liquid crystal display device comprising such composition and to a method of preparing such a composition and/or such a liquid crystal cell.
Patent EP-1905590-A2 (EP)
Inventor: SETO TAKESHI
IPC: A61B17/3203
Filed: 2007-09-25
Abstract: A fluid injection device includes: a pulse generation section (100) that includes a fluid chamber (501, 551), and an inlet flow passage (503, 521, 558) and an outlet flow passage (511); a first connection flow passage (201) connected to the outlet flow passage (511), having an end portion; a second connection flow passage (504) connected to the inlet flow passage (503, 521, 558); a fluid injection opening (212) formed at the end portion of the first connection flow passage (201), having a diameter smaller than the diameter of the outlet flow passage (511); a connection flow passage tube (200) including the first connection flow passage (201) and having rigidity adequate to transmit pulses of fluid flowing from the fluid chamber (501, 551) to the fluid injection opening (212); and a pressure generation section (20) that supplies fluid to the inlet flow passage (503, 521, 558).
Patent EP-1909044-A2 (EP)
Inventor: KOBAYASHI MASANORI
IPC: C02F103/02
Filed: 2007-09-26
Abstract: In an air filtering apparatus in which power is supplied from a power supply to electrodes in an electrolytic bath to electrolyze water in the electrolytic bath and thus generate electrolytic water and the generated electrolytic water and air are supplied to a gas-liquid contact member to filter the air, a voltage varying unit varies the voltage applied between the electrodes, and includes a voltage switching unit for switching a power supply voltage, a voltage adjusting unit for adjusting the power supply voltage switched by the voltage switching unit and applying the adjusted voltage between the electrodes and a controller for controlling the voltage switching unit so that the power supply voltage is adjusted to a voltage nearest to the adjusted power supply voltage by the voltage adjusting unit.
Patent EP-1923967-A2 (EP)
Inventor: REBENTISCH RONALD
IPC: H01R24/58
Filed: 2007-10-18
Abstract: The arrangement (11) has a cylindrical plug inserted into an opening (13) of a bush contact section, where the arrangement forms either a contact section of the plug or a contact section of a hollow-cylindrical bush (5). A contact unit (12, 12') comprises a set of fibers (15), which possesses metallic conductivity, where an end of the fibers protrudes into the opening and/or protrudes away from a lateral surface outwards. The contact unit comprises a fiber mat with a preset thickness.
Patent EP-1840283-A2 (EP)
IPC: E03F1/00
Filed: 2007-03-23
Abstract: The device (60) has a connecting unit, which is provided between a connecting pipe and a connector for a control arrangement of a purge or gate valve. The connecting unit of the closure device is lockable opposite to a low pressure pipe and/or the connecting pipe by using a check valve (100). A tubular or hose-shaped section (102) proceeds from the closure device, and exhibits the check valve on an end side of the tubular or hose-shaped section. The tubular or hose-shaped section extends up to a sewage flowing region of a low pressure sewage system.
Patent EP-1859953-A2 (EP)
Inventor: HOLTERHOFF KLAUS
IPC: B41J3/407
Filed: 2007-05-15
Abstract: The method involves using citronic acid for pre coating of non absorbent carriers (3). The citornic acid is applied on the carrier in powder form or fluid form. The citronic acid limits the ink in a temporal and localized manner, and polymerizes the ink used in a printer in a thermally inductive manner. The citronic acid is provided directly in the printer (1) or a station, connected indirectly to the printing machine, before printing.
Patent EP-1858264-A2 (EP)
Inventor: NAGANO TAKAHIRO
IPC: H04N9/07
Filed: 2007-05-15
Abstract: An imaging apparatus includes: an imaging section configured to approximate one of color matching functions representing sensitivity of the human eye to color by a spectral sensitivity that is obtained as a difference in output between, from among mutually adjacent photoelectric conversion elements, the photoelectric conversion elements arranged at predetermined positions, the imaging section having the photoelectric conversion elements arranged at the predetermined positions; and a signal processing section configured to apply to an output of the imaging section signal processing for converting an output of a photoelectric conversion element into a signal of a color image.
Patent EP-1855221-A2 (EP)
Title: Method and system for evaluating the performance of medical devices from a medication management unit
Inventor: HOLLAND GEOFFREY N
IPC: G06F19/00
Filed: 2004-10-07
Abstract: A medication management system (MMS) includes a medication management unit (MMU) associated with a medical device. The MMU downloads medication delivery code based on a medication delivery order to the medical device only if information from a first input matches information from a second input. The medical device receives delivery information electronically only from the MMU. The medication order is performed only after delivery data validation. The MMU also determines drug-drug incompatibility. The MMU can modulate (start, stop, sequence and dynamically adjust) medication order performance.
Patent EP-1925568-A2 (EP)
Inventor: KWIAT CHRISTINE LOUISE
IPC: A23L5/10
Filed: 2007-09-12
Abstract: The packaging system includes a first food product sealed within an inner wrapper, a second food product positioned within a tray and spacing the first food product from the tray, and an outer wrapper sealing the first food product, sealed within the inner wrapper, the second food product and the tray therein. A shield is disposed on the tray and is in contact with more than one surface of the second food product. Prior to microwave heating, the inner and outer wrapper are removed.
Patent EP-1986982-A2 (EP)
Inventor: KOTREL STEFAN
IPC: C07D213/06
Filed: 2007-02-07
Abstract: Die vorliegende Erfindung betrifft ein Verfahren zur Dehydrierung von dehydrierbaren Verbindungen bei einer Temperatur von 150 bis 400 °C in Gegenwart von Sauerstoff.
Patent EP-2003729-A2 (EP)
Inventor: UDAGAWA SHIGEO
IPC: H01Q1/52
Filed: 2007-02-19
Abstract: The present invention aims to provide an antenna apparatus that includes at least one choke in the form of a groove such that the amount of coupling between a transmitting antenna and a receiving antenna is suppressed more effectively than in conventional technology, and a method of manufacturing the antenna apparatus. The antenna apparatus according to the present invention includes a ground conductor 3, a first antenna 1 that is arranged on the ground conductor 3 and directly connected to a waveguide, a second antenna 2 that is arranged on the ground conductor 3, connected to another waveguide, and arranged at such a distance from the first antenna 1 that there is a possibility of mutual electromagnetic coupling with the first antenna 1, and a choke 4 in the form of a groove that is arranged between the first antenna 1 and the second antenna 2, and is used to suppress the mutual electromagnetic coupling between the first antenna 1 and the second antenna 2, and has a depth in a range from 0.15 times to less than 0.225 times of a wavelength of a carrier wave.
Patent EP-2018743-A2 (EP)
Inventor: OBERMANNS SEBASTIAN
IPC: H04L12/56
Filed: 2007-05-04
Abstract: What is provided is a method for communicating with a cellular network. The method is performed by a mobile computing device that comprises a transmitter and a receiver. One or more communication channels are monitored for one or more data packets that are transmitted by a base station of the cellular network during a transmission period. The transmission period can include one or more time slots. The mobile computing device determines whether one or more data packets have been received during a first time slot of the transmission period. In response to determining that no data packet has been received during the first time slot, the mobile computing device switches to an idle state until the transmission period ends.
Patent EP-1989911-A2 (EP)
Title: Procede de communication entre un terminal utilisateur sans fil et un point d'acces d'un reseau sans fil, terminal, point d'acces et programmes d'ordinateur associes
Inventor: LE SAGE BENOIT
IPC: H04W36/08
Filed: 2007-02-21
Abstract: Un procédé de communication entre des terminaux sans fil (6) et des points d'accès sans fil (AP1, AP2) d'au moins un réseau (4), chaque point d'accès étant associé à un canal radio respectif (canal 6, canal 1) pour connecter respectivement des terminaux à un des réseaux, comprend l'étape suivante lorsqu'un terminal est connecté à un des réseaux par l'intermédiaire d'un premier canal radio (canal 6) associé à un premier point d'accès (AP1) : émission sur le premier canal radio par au moins un second point d'accès (AP2) associé à un second canal (canal 1) distinct du premier canal, d'un message à destination du terminal.
Patent EP-2047391-A2 (EP)
Inventor: MARKRAM HENRY
IPC: G06Q10/00
Filed: 2007-05-30
Abstract: L'invention porte sur une méthode, un processus et un système techniques d'evaluation, publication et distillation d'informations, telles que des articles scientifiques ou autres travaux similaires comportant au moins les étapes suivantes: (1) processus interactif en ligne de révision de ladite information avant sa publication; (2) processus de publication de ladite information si acceptée; 3) processus d'évaluation de ladite information après sa publication; et 4) processus de distillation desdites informations publiées dans un système de filtrage à travées sur la base dudit processus d'évaluation.
Patent EP-2008257-A2 (EP)
Title: Protection d'enfants et de passagers vis-à-vis des dangers potentiels d'un véhicule
Inventor: SABAN ASHER S
IPC: G08B23/00
Filed: 2007-03-28
Abstract: La présente invention concerne un système (10) et des procédés pour réduire les dangers potentiels auxquels au moins un enfant (8) et des passagers (9) sont exposés au cours d'un trajet dans un véhicule (6) et lorsqu'ils se trouvent à l'extérieur et à côté du véhicule. La réduction des dangers potentiels auxquels un enfant est exposé est liée aux risques associés au comportement du conducteur (12) lorsqu'il est ou non en train de conduire le véhicule, lorsque l'enfant se trouve à l'intérieur ou à l'extérieur du véhicule, lorsque le véhicule se déplace sur des voies publiques et sur des voies privées, et suite à la non utilisation ou à une mauvaise utilisation de dispositifs dont dépendent enfants et passagers. Le système et les procédés impliquent l'entrée de commandes d'entrée actives dans un indicateur (14) pour faire fonctionner des éléments d'équipement (20) à bord du véhicule, comprenant des capteurs (22), des dispositifs fonctionnels (24) et des systèmes d'avertissement (26), et peuvent fonctionner pour assurer la communication avec des stations à distance, avec des véhicules adjacents dans la circulation, et avec les propriétaires des véhicules.
Patent EP-2033354-A2 (EP)
Title: Codage d'accusés de réception en liaison montante vers des transmissions en liaison descendante
Inventor: KIM BONG HOE
IPC: H04L1/00
Filed: 2007-06-18
Abstract: L'invention concerne un dispositif portatif, tel qu'un terminal mobile ou un équipement d'utilisateur, destiné au codage d'accusés de réception en liaison montante vers des transmissions en liaison descendante. Le dispositif portatif comprend un récepteur configuré de façon à recevoir une pluralité de blocs de données, de sorte que chacun de ces blocs de données comprenne un contrôle de redondance cyclique (CRC) associé et un processeur configuré de façon à déterminer le statut de réception de chacun des blocs de données en vérifiant le code CRC de chacun de ces blocs de données. Le dispositif portatif comprend en outre un émetteur permettant de transmettre une séquence en réponse qui indique le statut de réception de tous les blocs de données.
Patent EP-2037950-A2 (EP)
Inventor: HANSSON HANS-ARNE
IPC: A61K38/08
Filed: 2007-04-27
Abstract: La présente invention concerne l'utilisation d'une protéine antisécrétoire, d'un de ses dérivés, homologues et/ou fragments ayant une activité équivalente et/ou d'un de ses sels pharmaceutiquement actifs pour fabriquer une composition pharmaceutique et/ou un aliment thérapeutique destinés au traitement et/ou à la prévention d'un dysfonctionnement, par exemple une fonction anormale, une hypofonction ou hyperfonction des radeaux lipidiques, des récepteurs et/ou des cavéoles. La présente invention concerne également un dysfonctionnement des radeaux lipidiques, des récepteurs et/ou des cavéoles qui peut être provoqué par, ou être une cause de, diverses autres pathologies telles que des dysfonctionnements vasculaires et des dysfonctionnements pulmonaires et/ou des troubles endocrines, par exemple le diabète et les troubles apparentés. En outre, l'invention concerne un procédé de traitement et/ou de prévention d'un dysfonctionnement des radeaux lipidiques et/ou des cavéoles chez un mammifère nécessitant un tel traitement.
Patent EP-1986674-A2 (EP)
Inventor: TARARA THOMAS E
IPC: A61K38/16
Filed: 2007-02-13
Abstract: La présente invention concerne des compositions protéiques ou peptidiques contenant de la méthionine pouvant comporter au moins une protéine ou un peptide contenant de la méthionine et au moins un antioxydant inhibiteur de l'oxydation dudit peptide ou de ladite protéine contenant de la méthionine, les compositions étant inhalables. Des particules peuvent présenter une surface enrichie d'un excipient de surface ayant une température de transition vitreuse et un noyau enrichi d'au moins une protéine ou un peptide contenant de la méthionine. L'invention concerne également des procédés de fabrication, des procédés de traitement et des formes posologiques.
Patent EP-2002270-A2 (EP)
Title: Capteur hf miniature haute performance pour outils de traitement au plasma utilisés en microélectronique
Inventor: GARVIN CRAIG
IPC: G01R27/26
Filed: 2007-03-20
Abstract: L'invention concerne un capteur HF miniature haute performance maintenant des fonctions de gain, de directivité et d'isolation dans un boîtier miniature. Ce capteur HF miniature comprend des capteurs de courant et de tension superposés, disposés dans une structure de carte de circuit imprimé, le capteur comprenant en outre un filtre de transformation quart d'onde, un blindage triaxial, et un filtrage par effet pelliculaire
Patent EP-1986731-A2 (EP)
Inventor: PRUITT TERRELL
IPC: A61M5/315
Filed: 2007-02-08
Abstract: La présente invention concerne des procédés de délivrance de fluide et de matière et des dispositifs pour mettre les procédés en pratique. L'invention propose un procédé de délivrance de matière cellulaire comprenant d'injecter la matière cellulaire chez un sujet de sorte que les cellules injectées conservent leurs caractéristiques morphologiques inhérentes lors de l'injection. Le procédé comprend les étapes consistant à aspirer la matière cellulaire dans un dispositif de délivrance de fluide qui comprend une structure de seringue. La matière cellulaire est inspirée dans le corps principal de la seringue jusqu'à ce que la quantité souhaitée de matière ait rempli le corps de seringue. L'aiguille du dispositif de délivrance de fluide est ensuite introduite dans la peau d'un sujet selon un angle à peu près parallèle à la peau jusqu'à ce qu'une profondeur souhaitée soit atteinte. La matière cellulaire est ensuite injectée chez le sujet jusqu'à ce que le volume souhaité de matière soit injecté. L'aiguille du dispositif est ensuite tournée à approximativement 45 à 90 degrés et l'aiguille est retirée du site d'injection.
Patent EP-2040677-A2 (EP)
Inventor: DUNCALF DAVID JOHN
IPC: A23L27/00
Filed: 2007-06-29
Abstract: La présente invention concerne des antiparasitaires nanodispersés et une composition contenant au moins un médicament antiparasitaire insoluble dans l'eau et un excipient soluble dans l'eau, le médicament antiparasitaire insoluble dans l'eau (de préférence un médicament de type artémisinine ou un médicament de type quinine) étant dispersé dans l'excipient sous forme de nanodispersion présentant un diamètre maximal inférieur à 1000nm. L'invention concerne également une dispersion aqueuse d'un médicament antiparasitaire insoluble dans l'eau et d'un excipient soluble dans l'eau, le médicament antiparasitaire insoluble dans l'eau se présentant sous forme de nanodispersion présentant un diamètre maximal inférieur à 1000nm. L'invention concerne en outre un procédé de préparation d'une composition antiparasitaire contenant un agent antiparasitaire insoluble dans l'eau et un excipient soluble dans l'eau, consistant a) à former une émulsion contenant une solution de l'agent antiparasitaire dans un solvant non miscible dans l'eau et une solution aqueuse de l'excipient, ou à former un mélange comprenant au moins un solvant non aqueux, éventuellement de l'eau, un excipient soluble dans l'eau soluble dans le mélange et un agent antiparasitaire insoluble dans l'eau soluble dans le mélange, et b) à sécher l'émulsion (de préférence par séchage par pulvérisation) pour éliminer l'eau et le solvant non miscible dans l'eau afin d'obtenir une nanodispersion sensiblement exempte de solvant de l'agent antiparasitaire dans l'excipient.
Patent EP-2046956-A2 (EP)
Inventor: SUNKAR RAMANJULU
IPC: C12N15/12
Filed: 2007-04-05
Abstract: This invention provides variant sequences to miR398 targets in copper/zinc superoxide dismutase (CSD) genes resulting in resistance to down regulation of the CSD by the miR398.
Patent EP-2019860-A2 (EP)
Inventor: RUTTER WILLIAM J
IPC: C12N5/16
Filed: 2007-05-22
Abstract: The subject invention provides a site-specific integration system and methods for generating eukaryotic cells lines for protein production. The provided system includes a first site-specifically integrating target vector and a second site- specifically integrating donor vector comprising a gene of interest. Also provided are mammalian cell lines produced by the subject methods and systems, as well as kits that include the subject systems.
Patent EP-2043645-A2 (EP)
Inventor: ADELMAN DANIEL C
IPC: A61P35/00
Filed: 2007-06-12
Abstract: Compounds and compositions for treating, preventing or managing cancer are disclosed. The compositions provided herein comprise SNS-595 and N-desmethyl-SNS-595. Also provided are pharmaceutical compositions comprising the compounds and methods of treatment using the compounds and compositions.
Patent EP-2059474-A2 (EP)
Inventor: RICHTER HENNING
IPC: B82B3/00
Filed: 2007-08-31
Abstract: An in-situ method and system of collecting, in a liquid, non-agglomerated fullerenic material from a gaseous suspension is provided. The method and system collects non- agglomerated fullerenic material by contacting a gaseous suspension comprising fullerenic material with a suspension liquid, so as to capture the fullerenic material in the suspension liquid; and collecting the liquid suspension as a suspension liquid containing the fullerenic material. This method and system may be particularly useful for collecting fullerenes or nanotubes and maintaining them in solution in non-agglomerated states.
Patent EP-2061811-A2 (EP)
Inventor: SIADAK ANTHONY W
IPC: C12N5/18
Filed: 2007-09-04
Abstract: Novel compositions derived from antigen-binding sites of immunoglobulins having affinity for IL-31 are provided. The compositions exhibit immunological binding properties of antibody molecules capable of binding specifically to a human IL-31. CDR regions derived from same or different immunoglobulin moieties are provided. Also provided are single chain polypeptides wherein VH and VL domains are attached. The sFv molecules can include ancillary polypeptide moieties which can be bioactive, or which provide a site of attachment for other useful moieties. The compositions are useful in specific binding assays, affinity purification schemes, drug or toxin targeting, imaging, and genetic or immunological therapeutics for inflammatory diseases. The invention thus provides novel polypeptides, the DNAs encoding those polypeptides, expression cassettes comprising those DNAs, and methods of inducing the production of the polypeptides. The invention further provides the amino acid sequences of the variable regions of the monoclonal antibodies and use of these monoclonal antibody or antibody fragment in conjunction with an an human IgG4 Fc molecule.
Patent EP-2086496-A2 (EP)
Inventor: KOZLIK ARND
IPC: A47J41/00
Filed: 2007-10-26
Abstract: A drinks vessel, in particular a feeding bottle or a keg, is characterized in that the vessel (1) has a wall (15) and at least one element (5) with additional surfaces that intensify the heat exchange between the content of the vessel (1) and a cooling medium, in particular cooling water, wherein the additional surfaces have a total surface area of at least 50%, preferably at least 70%, of the surface of the wall (15) of the vessel (1) available for the heat exchange.